Terms: = Prostate cancer AND BCL7A, BCL7, 605, ENSG00000110987
89 results:
1. Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in cancer.
Prior O; Macarro C; Navarro V; Monreal C; Ligero M; Garcia-Ruiz A; Serna G; Simonetti S; Braña I; Vieito M; Escobar M; Capdevila J; Byrne AT; Dienstmann R; Toledo R; Nuciforo P; Garralda E; Grussu F; Bernatowicz K; Perez-Lopez R
Radiol Artif Intell; 2024 Mar; 6(2):e230118. PubMed ID: 38294307
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy.
Krsakova E; Cermak A; Fedorko M
J Hosp Infect; 2024 Mar; 145():83-87. PubMed ID: 38219833
[TBL] [Abstract] [Full Text] [Related]
3. Adverse events and costs among non-metastatic castration-resistant prostate cancer patients.
Appukkuttan S; Yao J; Partridge J; Kong SX; Parkin J; Freedland SJ
J Med Econ; 2024; 27(1):145-152. PubMed ID: 38174553
[TBL] [Abstract] [Full Text] [Related]
4. The Impact of Nutrient Supply on prostate cancer Risk Worldwide.
Jiang J; Yang J; Chen B; Li J; Zhang T; Tan D; Tang B; Wei Q
Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140390
[TBL] [Abstract] [Full Text] [Related]
5. Identification of differentially expressed circRNAs in prostate cancer of different clinical stages by RNA sequencing.
Wang X; Huang R; Yu J; Zhu F; Xi X; Huang Y; Zhang C; Hu H
Sci Rep; 2023 Dec; 13(1):21175. PubMed ID: 38040819
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic impact of palpable prostate tumors on disease progression after robot-assisted radical prostatectomy: a single-center experience.
Porcaro AB; Gallina S; Bianchi A; Tafuri A; Serafin E; Panunzio A; Mazzucato G; Orlando R; Ditonno F; Ornaghi PI; Rizzetto R; Cerrato C; De Marco V; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
J Robot Surg; 2023 Oct; 17(5):2471-2477. PubMed ID: 37486540
[TBL] [Abstract] [Full Text] [Related]
7. Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial.
Hasan S; Lazarev S; Garg M; Gozland R; Chang J; Hartsell W; Chen J; Tsai H; Vargas C; Simone CB; Gorovets D
Prostate; 2023 Jun; 83(9):850-856. PubMed ID: 36946610
[TBL] [Abstract] [Full Text] [Related]
8. Hsa_circ_0063329 inhibits prostate cancer growth and metastasis by modulating the miR-605-5p/tgif2 axis.
Lv D; Cen S; Yang S; Zou Z; Zhong J; Pan Z; Deng N; Li Y; Wu K; Wang J; Liu P
Cell Cycle; 2023 May; 22(9):1101-1115. PubMed ID: 36740902
[TBL] [Abstract] [Full Text] [Related]
9. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract] [Full Text] [Related]
10. Association between interleuleukin-1β polymorphism (rs16944) and biomarkers levels in Iraqi patients with prostate cancer.
Abed AS; Mokdad-Gargouri R; Raoof WM
Mol Biol Rep; 2023 Feb; 50(2):1157-1165. PubMed ID: 36417078
[TBL] [Abstract] [Full Text] [Related]
11. prostate cancer Screening Disparities in Persons Experiencing Homelessness.
Mayo ZS; Kilic SS; Weleff J; Parker SM; Strzalka C; Phelan M; Mian OY; Stephans KL; Suh JH; Tendulkar RD
JCO Oncol Pract; 2022 Nov; 18(11):e1866-e1873. PubMed ID: 36206501
[TBL] [Abstract] [Full Text] [Related]
12. Preoperative bullae and subsequent pneumothorax in 6605 patients who underwent robotic prostatectomy.
Yu J; Park JY; Lee J; Ha S; Hong JH; Kim YK
J Anesth; 2022 Dec; 36(6):740-746. PubMed ID: 36192651
[TBL] [Abstract] [Full Text] [Related]
13. Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment.
Liu X; Wang X; Zhang Y; Sun Z; Zhang X; Wang X
Abdom Radiol (NY); 2022 Sep; 47(9):3327-3337. PubMed ID: 35763053
[TBL] [Abstract] [Full Text] [Related]
14. Radiomic combination of spatial and temporal features extracted from DCE-MRI for prostate cancer detection
Fernandes CD; Mischi M; Wijkstra H; Barentsz JO; Heijmink SWTPJ; Turco S
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():3153-3156. PubMed ID: 34891910
[TBL] [Abstract] [Full Text] [Related]
15. The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis.
Piekarska K; Zacharczuk K; Wołkowicz T; Mokrzyś M; Wolaniuk N; Nowakowska M; Szempliński S; Dobruch J; Gierczyński R
Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):81. PubMed ID: 34876123
[TBL] [Abstract] [Full Text] [Related]
16. Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant prostate cancer.
Tu MM; Clemons M; Stober C; Jeong A; Vandermeer L; Mates M; Blanchette P; Joy AA; Aseyev O; Pond G; Fergusson D; Ng TL; Thavorn K
Curr Oncol; 2021 May; 28(3):1847-1856. PubMed ID: 34068083
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events.
Zeng KL; Sahgal A; Tseng CL; Myrehaug S; Soliman H; Detsky J; Atenafu EG; Lee Y; Campbell M; Maralani P; Husain ZA
Neurosurgery; 2021 Apr; 88(5):971-979. PubMed ID: 33475723
[TBL] [Abstract] [Full Text] [Related]
18. Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.
Zeng KL; Sahgal A; Husain ZA; Myrehaug S; Tseng CL; Detsky J; Sarfehnia A; Ruschin M; Campbell M; Foster M; Das S; Lipsman N; Bjarnason GA; Atenafu EG; Maralani PJ; Soliman H
J Neurooncol; 2021 Mar; 152(1):173-182. PubMed ID: 33453002
[TBL] [Abstract] [Full Text] [Related]
19. MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting bcl7a.
Dai J; Lu L; Kang L; Zhang J
Hum Cell; 2021 Mar; 34(2):624-633. PubMed ID: 33415690
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of Deep Learning to Augment Image-Guided Radiotherapy for Head and Neck and prostate cancers.
Oktay O; Nanavati J; Schwaighofer A; Carter D; Bristow M; Tanno R; Jena R; Barnett G; Noble D; Rimmer Y; Glocker B; O'Hara K; Bishop C; Alvarez-Valle J; Nori A
JAMA Netw Open; 2020 Nov; 3(11):e2027426. PubMed ID: 33252691
[TBL] [Abstract] [Full Text] [Related]
[Next]
